Feng Liu

发表

Generation, Characterization and Epitope Mapping of Two Neutralizing and Protective Human Recombinant Antibodies against Influenza A H5N1 Viruses

Qun Li, Y. Shu, J. Katz, 2009, PloS one.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Libo Dong, Feng Liu, F. Liu, 2009, The New England journal of medicine.

Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection

T. Uyeki, T. Tumpey, Zhu Guo, 2022, Scientific reports.

AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes.

F. Liu, J. Katz, Xiuhua Lu, 2015, Vaccine.

Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans

T. Tumpey, J. Katz, A. Bellamy, 2017, The Journal of infectious diseases.

Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations

F. Liu, J. Katz, Li-bo Dong, 2011, Journal of Clinical Microbiology.

Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice.

T. Monath, D. Lewis, F. Liu, 2012, Vaccine.

, Populations with 2009 Pandemic H 1 N 1 Virus in U . S . Assays for Detection of Human Infection Sensitivity and Specificity of Serologic

J. Katz, Li-bo Dong, Xiuhua Lu, 2011 .

Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice

Shiwen Wang, De-xin Li, Chuan Li, 2011, Virology Journal.

Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses.

J. Katz, H. Zeng, Xiuhua Lu, 2011, Journal of immunological methods.

Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.

R. Garten, L. Gubareva, Xiyan Xu, 2014, Virology.

Secretory Expression and Purification of Recombinant Escherichia coli Heat-Labile Enterotoxin B Subunit and its Applications on Intranasal Vaccination of Hantavirus

De-xin Li, Chuan Li, Qin-zhi Liu, 2009, Molecular biotechnology.

Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections

E. Reinherz, J. Katz, S. Sambhara, 2010, PloS one.

A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008.

L. Finelli, C. Bridges, F. Dawood, 2011, The Journal of infectious diseases.

Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity

C. Davis, T. Tumpey, J. Stevens, 2022, Vaccines.

Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin

T. Tumpey, D. Steinhauer, P. Carney, 2018, PloS one.

IgM, IgG, and IgA Antibody Responses to Influenza A(H1N1)pdm09 Hemagglutinin in Infected Persons during the First Wave of the 2009 Pandemic in the United States

P. Carney, J. Stevens, J. Katz, 2014, Clinical and Vaccine Immunology.

Age-specific effects of vaccine egg-adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.

Bin Zhou, Feng Liu, M. Levine, 2021, The Journal of clinical investigation.

Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans

J. Stevens, F. Liu, Zhu-Nan Li, 2016, Open forum infectious diseases.

Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Hong Sun, Libo Dong, Feng Liu, 2009 .

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost

T. Tumpey, J. Stevens, J. Katz, 2019, npj Vaccines.

Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.

W. Cao, T. Tumpey, J. Katz, 2014, Virology.

Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants

Xiyan Xu, T. Tumpey, J. Katz, 2017, The Journal of infectious diseases.

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.

F. Liu, T. Tumpey, Zhu Guo, 2017, Virology.

Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach—New York City, 2016–2017

J. Rakeman, L. Gould, F. Liu, 2018, The Journal of infectious diseases.

Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in Mice.

W. Cao, S. Sambhara, F. Liu, 2016, Viral immunology.

Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay

T. Tumpey, Jessie C. Chang, P. Carney, 2021, mBio.

Identification of novel influenza A virus exposures by an improved high‐throughput multiplex MAGPIX platform and serum adsorption

F. Liu, T. Tumpey, Jessie C. Chang, 2019, Influenza and other respiratory viruses.

Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis a virus infection in vitro and in vivo

Shengli Bi, F. Liu, De-xin Li, 2008, Journal of medical virology.

Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.

F. Liu, De-xin Li, Chuan Li, 2010, Vaccine.

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost

T. Tumpey, J. Stevens, B. Innis, 2019, npj Vaccines.

A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

D. Lewis, T. Tumpey, J. Katz, 2016, Virology.

Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination against Newly Emerged 2016-2018 A(H3N2) Variant Viruses in Healthy Persons.

F. Liu, M. Levine, Feng Liu, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.

M. Levine, Crystal Holiday, Yaohui Bai, 2016, Viral immunology.

Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

T. Popović, J. W. Stephens, F. Shaw, 2009, MMWR. Morbidity and mortality weekly report.